| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000028858 |
| Receipt No. | R000032938 |
| Scientific Title | A study to analyze antioxidant capacity of SEINETSUYAKU in Kampo using saliva |
| Date of disclosure of the study information | 2017/08/29 |
| Last modified on | 2020/02/29 (Ver. 9) |
| Basic information | ||
| Public title | A study to analyze antioxidant capacity of SEINETSUYAKU in Kampo using saliva | |
| Acronym | A study to analyze antioxidant capacity of SEINETSUYAKU in Kampo using saliva | |
| Scientific Title | A study to analyze antioxidant capacity of SEINETSUYAKU in Kampo using saliva | |
| Scientific Title:Acronym | A study to analyze antioxidant capacity of SEINETSUYAKU in Kampo using saliva | |
| Region |
|
|
| Condition | |||
| Condition | High value of oxidative stress | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the antioxidant capacity of Kampo medicine when ingested into the living body, analyzing the antioxidant capacity of saliva after rinsing the mouth with Kampo medicine decoctions such as SEINETSUYAKU(heat-clearing medicine). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Oxidation-reduction Potential(ORP) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Test agent1: Decoction of Ouren 3g.Dosage regimen: Collect saliva after rinsing the mouth for 1 minute with decoction(40ml). (single dose).In addition, 34 kinds of herbal medicine and 35 mixtures of herbal medicine are used as test agents.*26 kinds of herbal medicine(3g each):Ougon,Oubaku,Sanshishi,Sekkou,Chimo,Daiou,Saiko,Jiou,Kinginka,Koubei,Kanzou,Ninjin,Ryokucha.Kankyo,Shokyo,Taiso,Hange,Rengyo,Inchinko,Ryutan,Hakka,Soyo,Tanzin,Shyakuyaku,Botanpi,Boui.*8 kinds of herbal medicine:Ouren1.5g,Ouren1g,Ougon2.5g,Hange5g,Kankyo2.5g,Kanzo2.5g,Taiso2.5g,Ninjin2.5g.*15 mixtures of herbal medicine(gross weight of mixture: 3g each):Mixture of Ouren,Ougon,Oubaku,Sanshishi.Mixture of Ouren,Ougon,Oubaku.Mixture of Ouren,Ougon,Sanshishi.Mixture of Ouren,Oubaku,Sanshishi.Mixture of Ougon,Oubaku,Sanshishi.Mixture of Sekkou,Chimo,Koubei,Kanzou,Ninjin.Mixture of Sekkou,Chimo.Mixture of Sekkou decoction and Chimo decoction.Mixture of Ouren,Ougon.Mixture of Ouren,Oubaku.Mixture of Ouren, Sanshishi.Mixture of Ougon,Oubaku.Mixture of Ougon,,Sanshishi.Mixture of Oubaku,Sanshishi.Mixture of Ouren,Ougon,Hange,Kankyo,Kanzo,Taiso,Ninjin.*20 mixtures of herbal medicine(Prescription dose): Hangeshyashinto(Mixture of Ouren1g,Ougon2.5g,Hange5g,Kankyo2.5g,Kanzo2.5g,Taiso2.5g,Ninjin2.5g).Ourengedokuto(Mixture of Ouren1.5g,Ougon3g,Oubaku3g,Sanshishi3g).Mixture of Ouren,Ougon,Oubaku.Mixture of Ouren,Ougon, Sanshishi.Mixture of Ouren, Oubaku,Sanshishi.Mixture of Ougon,Oubaku,Sanshishi.Mixture of Ouren,Ougon.Mixture of Ouren, Oubaku.Mixture of Ouren,Sanshishi.Mixture of Ougon,Oubaku.Mixture of Ougon, Sanshishi.Mixture of Oubaku,Sanshishi.Precipitate part of the decoction (Mixture of Ouren,Ougong,Oubaku,Sanshishi).Supernatant part of the decoction (Mixture of Ouren,Ougon,Oubaku,Sanshishi). Ourengedokuto(Prescription 1/2dose),(Prescription 1/3dose), (Prescription 1/4dose). Hangeshyashinto(Prescription 1/2dose),(Prescription 1/3dose),(Prescription 1/4dose). | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Healthy adult
2. Subjects who agree to participate in this study with a written informed consent. |
|||
| Key exclusion criteria | 1. Person with serious underlying disease
2. Pregnant 3. Person currently or continuously taking Kampo medicine. 4.Person with history of adverse effects from taking Kampo medicine. |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | School of Pharmacy, Showa University | ||||||
| Division name | Department of Healthcare and Regulatory Science | ||||||
| Zip code | |||||||
| Address | 1-5-8 Hatanodai, Shinagawa-ku, Tokyo | ||||||
| TEL | 03-3784-8215 | ||||||
| s-iwai@pharm.showa-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | School of Pharmacy, Showa University | ||||||
| Division name | Department of Healthcare and Regulatory Science | ||||||
| Zip code | |||||||
| Address | 1-5-8 Hatanodai, Shinagawa-ku, Tokyo | ||||||
| TEL | 03-3784-8215 | ||||||
| Homepage URL | |||||||
| heiwado@nr.catv.ne.jp | |||||||
| Sponsor | |
| Institute | Showa University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Heiwado Pharmacy |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000032938 |